G GILD

Gilead Sciences Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Gilead Sciences, Inc. is a leading biopharmaceutical company based in Foster City, California, renowned for its pioneering advancements in antiviral therapeutics, especially for HIV and hepatitis. The company's innovative treatments, such as Harvoni and Sovaldi, have fundamentally transformed the ma...

$129.26

+1.18% (+$1.51)

Volume 5.90M

52W High $157.29

52W Low $93.34

Market Cap $159.83B

← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data

Consensus EPS

$1.91

Whisper EPS

$1.79

6.5% below consensus

Last Quarter

$0.00

Current Streak

1 Miss

Avg Surprise (4Q)

-49.73%

Next Earnings Report

Reports in 6 days

Report Date May 7, 2026

Time AMC

Whisper Spread -6.49%

Consensus Estimate

$1.91

Official analyst average

Whisper Number

$1.79

What traders expect

Cautious Sentiment: The whisper number is 6.5% below consensus, suggesting traders are skeptical. Meeting consensus may not be enough to satisfy the market.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q1 2026 Apr 23, 2026

1-Day: -2.42%

5-Day: -3.28%

Q4 2025 Feb 10, 2026

1-Day: +5.82%

Q3 2025 Oct 30, 2025

1-Day: +1.14%

5-Day: +3.85%

Q2 2025 Aug 7, 2025

1-Day: +8.28%

5-Day: +8.83%

Revenue & Financial Performance

Revenue Whisper

$7.54B

TWN Proprietary Estimate

Last Quarter Revenue

$7.93B

+4.7% YoY

Gross Margin

86.8%

Net Margin: 27.6%

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$7.93B	+4.7%	86.8%	37.4%	$2.18B
Q3'25	$7.77B	+3.0%	79.8%	42.8%	$3.05B
Q2'25	$7.08B	+1.8%	78.8%	34.9%	$1.96B
Q1'25	$6.67B	-0.3%	76.9%	33.6%	$1.32B
Q4'24	$7.57B	+6.4%	79.1%	32.4%	$1.78B
Q3'24	$7.55B	+7.0%	79.1%	11.8%	$1.25B
Q2'24	$6.95B	+5.4%	77.8%	38.0%	$1.61B
Q1'24	$6.69B	+5.3%	76.8%	-64.6%	-$4.17B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	Apr 23, 2026	$1.89	$1.96	$0.00	-100.00%	Missed
Q4 2025	Feb 10, 2026	$1.85	$1.90	$1.86	+0.54%	Missed
Q3 2025	Oct 30, 2025	$2.15	$2.32	$2.47	+14.88%	Beat
Q2 2025	Aug 7, 2025	$1.96	$2.15	$2.01	+2.55%	Missed
Q1 2025	May 8, 2025	$1.77	$1.94	$1.81	+2.11%	Missed
Q4 2024	Feb 4, 2025	$1.70	$1.85	$1.90	+11.73%	Beat
Q3 2024	Nov 6, 2024	$1.55	$1.66	$2.02	+30.32%	Beat
Q2 2024	Aug 8, 2024	$1.60	$1.69	$2.01	+25.62%	Beat
Q1 2024	Apr 25, 2024	-$1.49	-$1.49	-$1.32	+11.41%	Beat
Q4 2023	Feb 6, 2024	$1.76	$1.84	$1.72	-2.27%	Missed
Q3 2023	Nov 7, 2023	$1.92	$2.04	$2.29	+19.27%	Beat
Q2 2023	Aug 3, 2023	$1.64	$1.75	$1.66	+1.22%	Missed